Risk of selected gastrointestinal toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of ovarian cancer: a meta-analysis of published trials

AIMS: We aimed to comprehensively assess the risk of gastrointestinal toxicities associated with poly (ADP-ribose) polymerase inhibitors (PARPis) in the treatment of ovarian cancer patients. MATERIALS AND METHODS: We searched several databases for relevant trials. Eligible studies included prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yongping, Meng, Jun, Wang, Guichan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147204/
https://www.ncbi.nlm.nih.gov/pubmed/30271116
http://dx.doi.org/10.2147/DDDT.S164553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147204/
https://www.ncbi.nlm.nih.gov/pubmed/30271116
http://dx.doi.org/10.2147/DDDT.S164553

Ejemplares similares